Why Does the Opposition Swallow Big Pharma’s Narrative?

Spike Protein Claims

originally published at

The Curious Contrarian

The “Resistance” continues to promote unverifiable ideas that benefit pharmaceutical companies. Well-paid “freedom” personalities repeatedly assert that the spike protein is extraordinarily dangerous. We are inundated with tales of shedding and spike protein horrors. But is this merely another gimmick? A distraction? A means to divert our attention from more pressing issues? Another way to instill panic about an imaginary threat? Are we perpetually directing our focus toward something that contributes nothing to our liberation?

Stefano Scoglio¹, whom I have previously written about, stated:

"Anybody who talks about spike proteins and embraces the story diffused by the pharmaceutical companies just accepts that as given."

Pharmaceutical companies frequently claim to have discovered or created something extraordinary. When opposition leaders concur that these companies have produced something significant, doesn’t that warrant skepticism?

Do these transfections—now rebranded as “gene therapy”—actually transform our bodies into “spike protein factories”? I am uncertain. I wish to learn more and write more about this topic and I plan to invest considerable time in investigating these claims. However, today I simply want to highlight that pharmaceutical corporations and their researchers have historically made numerous assertions that later proved untrue. Unfortunately, it can take decades to uncover that an initial hypothesis was incorrect. Will we permit them to escape scrutiny regarding the spike protein? Or will we take it upon ourselves to investigate these new claims?

In 1984, it was posited that amyloid plaques caused Alzheimer’s disease, based on their accumulation in patients’ brains. By 2017, this hypothesis was called into question after observations showed that drugs designed to eliminate these plaques did not benefit Alzheimer’s patients. Novel drugs, marketed as effective treatments, caused significant brain bleeding and swelling in 20% to 37% of those in the active-treatment group and were exorbitantly priced—lecanemab at $26,000 per year and aducanumab at $56,000 annually. A 2022 paper unveiled new evidence that fundamentally altered our understanding of Alzheimer’s disease progression.

This research explains why many experimental therapies aimed at amyloid plaque removal failed: by the time these protein accumulations are evident, brain cells have already begun malfunctioning and cannot effectively clear the debris from the plaques.

Why do we have such unwavering confidence in the narratives spun by pharmaceutical companies claiming their products perform as advertised? Numerous examples show that claims and hypotheses have been disproven decades or even centuries later. Why do prominent “freedom” and “truth” influencers persist in disseminating fear about the spike protein when that only bolsters the credibility of pharmaceutical companies—an industry that deserves skepticism due to its resistance to questions and new findings that could undermine its long-term financial outlook?

“That mRNA “vaccines” cause cells to produce spike proteins is a fairy tale”

1.